ABSA International
ABSA International

Resources with keywords: vaccination

Training Tools & Resources
EIDC Toolboxes


Information For Veterinarians
CDC
27 May 2022

Includes information for public health veterinarians and animal health officials

keywords: Monkeypox, poxvirus, vaccination
Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
CDC/MMWR
27 May 2022

Rao AK, Petersen BW, Whitehill F, et al.

keywords: JYNNEOS, Monkeypox, poxvirus, vaccination
FACT SHEET: Biden-⁠Harris Administration’s Monkeypox Outbreak Response
White House
28 June 2022
keywords: Monkeypox, poxvirus, vaccination
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022
CDC/MMWR
28 June 2022
keywords: children, covid-19, pediatric vaccines, vaccination, vaccines
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 (NEW 5/6, Website, Publication)
CDC/MMWR
22 April 2022

Shi DS, Whitaker M, Marks KJ, et al.

keywords: children, covid-19, hospitalization, vaccination
Do I qualify for a COVID-19 vaccine booster and which one? (Website, Regulatory)
FDA

Use this chart to find out if you’re eligible for a COVID-19 vaccine booster and which one.

keywords: booster, covid-19, vaccination
Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals (Website, Regulatory)
FDA
29 March 2022

The FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.

keywords: booster, covid-19, vaccination
Association of COVID-19 Vaccination During Early Pregnancy With Risk of Congenital Fetal Anomalies (NEW 5/6, Website, Publication)
JAMA
4 April 2022

Ruderman RS, Mormol J, Trawick E, et al

keywords: covid-19, pregnancy, vaccination
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022 (Website, Publication)
CDC/MMWR
15 February 2022

Halasa NB, Olson SM, Staat MA, et al.
Completion of a 2-dose mRNA COVID-19 vaccination series during pregnancy might help prevent COVID-19 hospitalization among infants aged <6 months.

keywords: covid-19, pregnancy, vaccination
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021 (NEW 2/3, Website, Publication)
JAMA Network
25 January 2022

Oster ME, et al.

In this descriptive study of 1626 cases of myocarditis in a national passive reporting system, the crude reporting rates within 7 days after vaccination exceeded the expected rates across multiple age and sex strata.

keywords: covid-19, myocarditis, vaccination

Not a member and would like updates and notifications?

ABSA International
1200 Allanson Road, Mundelein, IL 60060-3808
1-866-425-1385 (toll free) or 847-949-1517
info@absa.org | Contact ABSA

ABOUT | MEMBERSHIP | NEWS/COMMUNITY | RESOURCES | PUBLICATIONS | CREDENTIALS | PROFESSIONAL DEVELOPMENT

For a complete view of the web presence of ABSA International, see the ABSA Portal page.

Copyright © ABSA International. All Rights Reserved.  Privacy Policy

ABSA International does not endorse, promote, review, or warrant the accuracy of the products and services offered by those parties who link to the ABSA International website. The links are merely provided as a convenience to the visitors of this site, and ABSA International may or may not be compensated for permitting the link to be displayed on this page.

Go to Top